Suda et al. (2021) examined EGFR gene mutations in 5780 Japanese lung cancer patients, 2410 patients had EGFR gene mutations (41.7%), 983 patients had 19-del mutations (40.8%), whereas 1170 patients displayed L858R point mutation (48.5%) [48]. The gene discussed is EGFR; the disease is lung carcinoma.